cbdMD, Inc. (YCBD)
0.488
-0.02
(-4.11%)
USD |
NYAM |
Aug 24, 16:00
cbdMD Max Drawdown (5Y) : 99.98% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.98% |
| June 30, 2026 | 99.98% |
| May 31, 2026 | 99.98% |
| April 30, 2026 | 99.98% |
| March 31, 2026 | 99.98% |
| February 28, 2026 | 99.98% |
| January 31, 2026 | 99.98% |
| December 31, 2025 | 99.98% |
| November 30, 2025 | 99.98% |
| October 31, 2025 | 99.97% |
| September 30, 2025 | 99.97% |
| August 31, 2025 | 99.97% |
| July 31, 2025 | 99.96% |
| June 30, 2025 | 99.96% |
| May 31, 2025 | 99.96% |
| April 30, 2025 | 99.92% |
| March 31, 2025 | 99.92% |
| February 28, 2025 | 99.88% |
| January 31, 2025 | 99.88% |
| December 31, 2024 | 99.88% |
| November 30, 2024 | 99.85% |
| October 31, 2024 | 99.85% |
| September 30, 2024 | 99.84% |
| August 31, 2024 | 99.83% |
| July 31, 2024 | 99.81% |
| Date | Value |
|---|---|
| June 30, 2024 | 99.81% |
| May 31, 2024 | 99.81% |
| April 30, 2024 | 99.81% |
| March 31, 2024 | 99.81% |
| February 29, 2024 | 99.81% |
| January 31, 2024 | 99.81% |
| December 31, 2023 | 99.81% |
| November 30, 2023 | 99.81% |
| October 31, 2023 | 99.81% |
| September 30, 2023 | 99.66% |
| August 31, 2023 | 99.66% |
| July 31, 2023 | 99.56% |
| June 30, 2023 | 99.54% |
| May 31, 2023 | 99.41% |
| April 30, 2023 | 98.92% |
| March 31, 2023 | 97.70% |
| February 28, 2023 | 96.75% |
| January 31, 2023 | 96.75% |
| December 31, 2022 | 96.75% |
| November 30, 2022 | 96.74% |
| October 31, 2022 | 96.74% |
| September 30, 2022 | 96.74% |
| August 31, 2022 | 94.53% |
| July 31, 2022 | 94.53% |
| June 30, 2022 | 93.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Tilray Brands, Inc. | 99.44% |
| Organogenesis Holdings, Inc. | 98.74% |
| Guardian Pharmacy Services, Inc. | -- |
| Nektar Therapeutics | 99.39% |
| Elite Pharmaceuticals, Inc. | 87.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -101.12 |
| Beta (5Y) | 2.142 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 110.6% |
| Historical Sharpe Ratio (5Y) | -0.7357 |
| Historical Sortino (5Y) | -1.558 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 46.41% |